The Gut Microbiome and Nonalcoholic Steatohepatitis.
作者信息
Schattenberg Jörn M
机构信息
Professor of Medicine Director, Metabolic Liver Research Program I. Department of Medicine University Medical Center Mainz Mainz, Germany.
出版信息
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):166-168.
Abstract
摘要
相似文献
1
The Gut Microbiome and Nonalcoholic Steatohepatitis.肠道微生物群与非酒精性脂肪性肝炎
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):166-168.
2
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.综述文章：肠道微生物组在非酒精性脂肪性肝病进展中的新作用及其潜在的治疗意义。
Aliment Pharmacol Ther. 2019 Jul;50(2):144-158. doi: 10.1111/apt.15314. Epub 2019 May 31.
3
Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery.肠道微生物群及其相关代谢产物在非酒精性脂肪性肝炎发病机制中的作用以及减肥手术后的缓解情况
Obes Rev. 2022 Feb;23(2):e13367. doi: 10.1111/obr.13367. Epub 2021 Nov 2.
4
Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis.肠道微生物群和脂质组的协同变化可将非酒精性脂肪性肝炎（NASH）与单纯性脂肪变性区分开来。
Liver Int. 2020 Mar;40(3):622-637. doi: 10.1111/liv.14316. Epub 2019 Dec 30.
5
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome.非酒精性脂肪性肝病和非酒精性脂肪性肝炎有前景的诊断生物标志物：从临床蛋白质组学到微生物组
World J Hepatol. 2021 Nov 27;13(11):1494-1511. doi: 10.4254/wjh.v13.i11.1494.
6
Soyasaponin A Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice.大豆皂苷 A 可能通过调节蛋氨酸和胆碱缺乏（MCD）饮食诱导的非酒精性脂肪性肝炎（NASH）小鼠的胆汁酸和肠道微生物群来缓解肝脂肪变性。
Mol Nutr Food Res. 2021 Jul;65(14):e2100067. doi: 10.1002/mnfr.202100067. Epub 2021 Jun 10.
7
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.肠道微生物群对非酒精性脂肪性肝炎发生发展的影响。
Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5.
8
Lower gut microbiome diversity and higher abundance of proinflammatory genus are associated with biopsy-proven nonalcoholic steatohepatitis.下消化道微生物多样性降低和促炎属的丰度增加与活检证实的非酒精性脂肪性肝炎有关。
Gut Microbes. 2020 May 3;11(3):569-580. doi: 10.1080/19490976.2019.1681861. Epub 2019 Nov 7.
9
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.实验性脂肪性肝炎小鼠模型中肠道微生物群组成及免疫反应的改变
Dig Dis Sci. 2017 Feb;62(2):396-406. doi: 10.1007/s10620-016-4393-x. Epub 2016 Dec 2.
10
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.非酒精性脂肪性肝病与肠道微生物组。
Clin Liver Dis. 2016 May;20(2):263-75. doi: 10.1016/j.cld.2015.10.012. Epub 2015 Dec 24.
本文引用的文献
1
The gut microbiota instructs the hepatic endothelial cell transcriptome.肠道微生物群指导肝内皮细胞转录组。
iScience. 2021 Sep 10;24(10):103092. doi: 10.1016/j.isci.2021.103092. eCollection 2021 Oct 22.
2
Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches.非酒精性脂肪性肝病治疗范式的转变：从病理生理学到新型饮食方法。
Nutrients. 2021 Jun 8;13(6):1977. doi: 10.3390/nu13061977.
3
Nonalcoholic Fatty Liver Disease in 2020.2020年的非酒精性脂肪性肝病
Gastroenterology. 2020 May;158(7):1849-1850. doi: 10.1053/j.gastro.2020.04.013. Epub 2020 Apr 14.
4
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program.基于个体化、基于网络的运动方案改善非酒精性脂肪性肝病的非侵入性标志物。
Aliment Pharmacol Ther. 2019 Oct;50(8):930-939. doi: 10.1111/apt.15427. Epub 2019 Jul 25.
5
Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.非酒精性脂肪性肝炎（NASH）瘦患者的肠道微生物群组成与肝损伤相关，且独立于热量摄入：一项前瞻性试点研究。
Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):369-384. doi: 10.1016/j.numecd.2017.10.014. Epub 2017 Oct 26.
6
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.非酒精性脂肪性肝病的严重程度与肠道菌群失调及肠道微生物群代谢功能的改变有关。
Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.
Zotero 插件